Tower microneedle minimizes vitreal reflux in intravitreal injection

Biomedical Microdevices

Volumn 15, Issue 5, 2013, Pages 841-848

  Lee, Chang Yeol ^a   You, Yong Sung ^b   Lee, Sung Ho ^c   Jung, Hyungil ^a  

^a Yonsei University   (South Korea)

^b NUNE Eye Hospital   (South Korea)

^c Lumieye Genetics Co Ltd   (South Korea)

Author keywords

Bleb; Intravitreal injectin; Microneedle; Ocuular drug delivery; Reflux

Indexed keywords

BLEB; INTRA OCULAR PRESSURE; INTRAVITREAL INJECTIN; INTRAVITREAL INJECTION; MICRONEEDLES; PHENYLEPHRINE HYDROCHLORIDE; REFLUX; THERAPEUTIC EFFECTS;

DRUG DELIVERY; DRUG DOSAGE; TOWERS;

NEEDLES;

FLUORESCEIN SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CILIARY DISK; CONTROLLED STUDY; HYPODERMIC NEEDLE; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MICRONEEDLE; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PUPIL; RABBIT; SCLERA; TOWER MICRONEEDLE; VITREOUS BODY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; NEEDLES; PHENYLEPHRINE; RABBITS; SYMPATHOMIMETICS; VITREOUS BODY;

EID: 84884350843     PISSN: 13872176     EISSN: 15728781     Source Type: Journal    
DOI: 10.1007/s10544-013-9771-y     Document Type: Article

References (23)

1. M.W. Ashraf, S. Tayyaba, A. Nisar, N. Afzulpurkar, D.W. Bodhale, T. Lomas, A. Poyai, A. Tuantranont, Design, fabrication and analysis of silicon hollow microneedles for transdermal drug delivery system for treatment of hemodynamic dysfunctions. Cardiovasc. Eng. 10, 91-108 (2010)
2. T. Avitabile, F. Marano, F. Castiglione, C. Bucolo, M. Cro, L. Ambrosio, C. Ferrauto, A. Reibaldi, Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits. Biomaterials 22, 195-200 (2001)
3. R.T. Cortez, G. Ramirez, L. Collet, P. Thakuria, G.P. Giuliari, Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits. Arch. Ophthalmol. 128, 884-887 (2010)
4. S. Duvvuri, S. Majumdar, A.K. Mitra, Drug delivery to the retina: challenges and opportunities. Expert. Opin. Biol. Ther. 3, 45-56 (2003)
5. A.E. Fung, P.J. Rosenfeld, E. Reichel, The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br. J. Ophthalmol. 90, 1344-1349 (2006)
6. M. Hornof, E. Toropainen, A. Urtti, Cell culture models of the ocular barriers. Eur. J. Pharm. Biopharm. 60, 207-225 (2005)
7. J. Hsu, Drug delivery methods for posterior segment disease. Curr. Opin. Ophthalmol. 18, 235-239 (2007)
8. P.M. Hughes, O. Olejnik, J.E. Chang-Lin, C.G. Wilson, Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57, 2010-2032 (2005)
9. R.D. Jager, L.P. Aiello, S.C. Patel, E.T. Jr Cunningham, Risks of intravitreous injection: a comprehensive review. Retina 24, 676-698 (2004)
10. K.G. Janoria, S. Gunda, S.H. Boddu, A.K. Mitra, Novel approaches to retinal drug delivery. Expert Opin. Drug Deliv. 4, 371-388 (2007)
11. J. Jiang, H.S. Gill, D. Ghate, B.E. McCarey, S.R. Patel, H.F. Edelhauser, M.R. Prausnitz, Coated microneedles for drug delivery to the eye. Invest. Ophthalmol. Vis. Sci. 48, 4038-4043 (2007)
12. J. Jiang, J.S. Moore, H.F. Edelhauser, M.R. Prausnitz, Intrascleral drug delivery to the eye using hollow microneedles. Pharm. Res. 26, 395-403 (2009)
13. A. Laude, L.E. Tan, C.G. Wilson, G. Lascaratos, M. Elashry, T. Aslam, N. Patton, B. Dhillon, Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog. Retin. Eye Res. 29, 466-475 (2010)
14. K. Lee, H.C. Lee, D.S. Lee, H. Jung, Drawing lithography: three-dimensional fabrication of an ultrahigh-aspect-ratio microneedle. Adv. Mater. 22, 483-486 (2010)
15. C.Y. Lee, K. Lee, Y.S. You, S.H. Lee, H. Jung, Tower microneedle via reverse drawing lithography for innocuous intravitreal drug delivery. Adv. Healthc. Mater (2012). doi: 10.1002/adhm.201200239
16. K. Lorenz, I. Zwiener, A. Mirshahi, Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle. Graefes Arch. Clin. Exp. Ophthalmol. 248, 1573-1577 (2010)
17. D.W. Lu, C.J. Chang, C.H. Chiang, M.K. Yeh, P.I. Chou, Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits. J. Ocul. Pharmacol. Ther. 16, 529-538 (2000)
18. D.V. McAllister, P.M. Wang, S.P. Davis, J.H. Park, P.J. Canatella, M.G. Allen, M.R. Prausnitz, Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl. Acad. Sci. U. S. A. 100, 13755-13760 (2003)
19. S.R. Patel, D.E. Berezovsky, B.E. McCarey, V. Zarnitsyn, H.F. Edelhauser, M.R. Prausnitz, Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest. Ophthalmol. Vis. Sci. 53, 4433-4441 (2012)
20. G.A. Peyman, E.M. Lad, D.M. Moshfeghi, Intravitreal injection of therapeutic agents. Retina 29, 875-912 (2009)
21. J.S. Pulido, C.M. Pulido, S.J. Bakri, C.A. McCannel, J.D. Cameron, The use of 31-gauge needles and syringes for intraocular injections. Eye 21, 829-830 (2007)
22. E.B. Rodrigues, C.H. Meyer, A. Jr Grumann, H. Shiroma, J.S. Aguni, M.E. Farah, Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am. J. Ophthalmol. 143, 1035-1037 (2007)
23. R.P. Singh, H. Bando, O.F. Brasil, D.R. Williams, P.K. Kaiser, Evaluation of wound closure using different incision techniques with 23-gauge and 25-gauge microincision vitrectomy systems. Retina 28, 242-248 (2008)